A new research report published by Infinium Global Research identified that the global translational regenerative medicine market is set to grow on the backdrop of rising awareness among people regarding regenerative medicines, increasing government initiatives across various countries in the world and growing elderly population & healthcare expenditure are considered to be the key factors driving the growth of global translational regenerative medicine market

Pune, India -- (SBWire) -- 02/02/2018 --A new research report published by Infinium Global Research identified that the global translational regenerative medicine market is set to grow on the backdrop of rising awareness among people regarding regenerative medicines, increasing government initiatives across various countries in the world and growing elderly population & healthcare expenditure are considered to be the key factors driving the growth of global translational regenerative medicine market. Increase in adoption of regenerative medicines is expected to bring new opportunities. The global market size of translational Regenerative Medicine was USD 9.83 Billion in growing at a CAGR of 23.4% between 2016 and 2022.

Get Free Sample Pages of this Report: https://www.infiniumglobalresearch.com/Reports/MakeSampleRequest/302

North America is the largest market for regenerative medicines and accounted highest market shares as of 2015. Presence of medical reimbursement facilities and technological advancements in the region are considered to be the key factors driving the dominance of North America in global regenerative medicines market. Following North America, Asia pacific was the second largest market for translational regenerative medicines over 2015 and 2016; and it is anticipated to witness healthy CAGR over the forecast period. The growth of Asia pacific translational regenerative medicine market is considered to be driven by rapidly increasing per capita healthcare expenditure and higher focus on research in regenerative medicines by key players across the region. Developing economies in Asia pacific such as India and China are likely to bring more opportunities for major player over the forecast period.

Government support across countries worldwide to escalate the growth in translational regenerative medicine market in near future

In the US, government enacted laws to provide tax benefits for research and development activities. Orphan drug act, 1983 incentivizes development of drugs for treatment of illnesses affecting more than 200000 people. Housing and Economic recovery act of 2008 provides exceptions for companies that do not have income yet from research, to avail cash refunds upon depreciation of capital investments during that time frame. Likewise, many governments across the globe are promoting the new technologies for treating various serious diseases in their healthcare system. It drives the growth of the market.

Browse the detailed TOC of the report on translational regenerative medicine market: https://www.infiniumglobalresearch.com/healthcare_medical_devices/global_translational_regenerative_medicine_market

The report segments the global translational regenerative medicine market as:

Market segment based on Product Type
- Tissue Engineered Products
- Cell Based Products
- Gene Therapy Products

Market segment based on Application
- Orthopedic
- Dermatology
- Cardiovascular
- Neurology
- Oncology
- Diabetes
- Others

Companies Covered in this Report:
- Anika Therapeutics
- Nuvasive, Inc.
- Orthofix International N.V.
- MEDIPOST
- Athersys, Inc.
- Celgene Corporation
- Vericel Corporation
- Novartis
- Brainstorm Cell Therapeutics Inc.
- Anterogen, Gamida Cell Ltd.
- RTI Surgical, Inc.